Dr. Daniel E. Furst, MD

Dr. Furst practices at Seattle Rheumatology Associates in Seattle, Washington.

Dr. Furst's NPI, 1821023599, was assigned on July 11, 2006. Dr. Furst graduated from The Johns Hopkins University School of Medicine in 1968. Dr. Furst's California license number on file is G26247.

Dr. Furst's primary practice is Seattle Rheumatology Associates, at 601 Broadway, Seattle, WA 98122 in King County. The practice phone is (206) 844-6001.

Dr. Furst's primary practice is Seattle Rheumatology Associates in Seattle, Washington. Dr. Furst is also affiliated with Hoag Hospital Newport Beach. The medical group on file is Seattle Rheumatology Associates. Dmand AI also links Dr. Furst to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Furst practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Furst's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Furst is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Furst's licenses on file in 4 states: California, Washington, New Jersey and Iowa.

Dmand AI lists arteritis, arthritis, lupus, muscle pain, fibromyalgia, and limb pain, osteoporosis and rheumatoid arthritis among the conditions Dr. Furst treats.

CMS data shows 49 Medicare services from Dr. Furst across 1 procedure code in 2024, all of them office visits, for 21 Medicare patients. Medicare paid $7,418 for them. Every service was in an office.

CMS counts 21 Medicare patients who saw Dr. Furst in 2024. 75% of them have arthritis, and 67% have high blood pressure. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Furst's median patient age at 63, with 82% women.

In 2024, Dr. Furst wrote 1,347 Medicare Part D claims for 88 patients. 82% of them were for generic drugs. CMS names the drug for 809 of them, across 40 drugs with 11 or more claims each, at $582,832 in total drug cost. In 2023, CMS named 964 claims across 46 drugs.

Dr. Furst accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Furst as offering telehealth.

Dmand AI links 472 papers to Dr. Furst, published from 2004 to 2025. 2016 was the busiest year, with 17. The most frequent topics are Scleroderma, Systemic, Arthritis, Rheumatoid and Antirheumatic Agents. Dr. Furst has published most often in J Rheumatol. Dr. Furst's most frequent co-authors are Maureen D. Mayes, MD, Dinesh Khanna, MD and Vibeke Strand, MD.

Dmand AI links Dr. Furst to 14 clinical trials, 4 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Scleroderma, Systemic, Scleroderma, Diffuse and Arthritis, Rheumatoid. University of California, Los Angeles sponsors the most, 4. Open Payments lists research payments to Dr. Furst that name 1 trial.

CMS Open Payments shows 1,070 general payments to Dr. Furst from 51 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Bristol-Myers Squibb Company paid the most, $40,499. It also lists 46 research payments totaling $55,144 from 2017 to 2025, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Furst.

Dr. Furst graduated from The Johns Hopkins University School of Medicine in 1968. Dr. Furst is a member of ACR and ACR.

Dr. Furst is in network with 7 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.